. Author manuscript; available in PMC: 2014 Jan 3.

Published in final edited form as: Surgery. 2011 Dec;150(6):10.1016/j.surg.2011.09.043. doi: 10.1016/j.surg.2011.09.043

Table III.

Stage distribution of cohort

Stage^*	Total, n (%)	Therapeutic (sporadic), n (%)	Therapeutic (hereditary), n (%)	Prophylactic, n (%)
I (stage 1: T1N0M0)	52 (50)	30 (40)	9 (56)	13 (100)
II (stage 2: T2/T3N0M0)	19 (18)	16 (21)	3 (19)	0 (0)
III (stage III: T1–T3N1aM0)	5 (5)	4 (5)	1 (6)	0 (0)
IV (stage IV: T4aN0/N1aM0 or T1–T4aN1bM0)	28 (27)	25 (33)	3 (18)	0 (0)

According to the AJCC Cancer Staging Manual, 7th edition (2009).

Patients with known distant metastasis (M1) were excluded from the study.